PRINCETON, NJ--(MARKET WIRE)--Jul 5, 2006 -- Barrier Therapeutics, Inc. (Nasdaq:BTRX - News), a pharmaceutical company developing and commercializing products in the field of dermatology, today announced that Geert Cauwenbergh, Ph.D., Chief Executive Officer, is scheduled to present to the investment community at the C.E. Unterberg, Towbin Emerging Growth Conference.
